Fingerpaint Branding is proud to support pharmaceutical and life sciences companies around the globe with naming, visual identity, brand strategy, market research, and regulatory guidance. Here are a few of our most recent brand name and non-proprietary name approvals.

Fingerpaint Branding Approvals Vimkunya Winrevair Ohtuvayre Miplyffa Grafapex Journavx Unloxcyt Yorvipath Zunveyl Nemluvio Alyftrek Kebilidi Casgevy Sohonos Zurzuvae Vowst Omisirge Augtyro Sovuna Ogsiveo Elahere Sunlenca Skyrizi Gemtesa Triferic Avnu Trodelvy Yescarta Zoryve Vyjuvek Cyfendus Briumvi Tzield Torpenz Xdemvy Orgovyx Vueway Daybue Ocrevus Zunovo Veopoz
  • adrulipase alfa

  • alnuctamab

  • anumigilimab

  • anzurstobart

  • atamparib

  • avutometinib

  • bezetabart debotansine

  • bomedemstat

  • bomtabegagene bavoparvovec

  • brexucabtagene autoleucel

  • camizestrant

  • casirivimab/imdevimab

  • cavrotolimod

  • cliramitug

  • dimebutic acid

  • dordaviprone

  • dovramilast

  • duvakitug

  • eclitasertib

  • efzimfotase alfa

  • eganelisib

  • eladocagene exuparvovec

  • emvododstat

  • eragidomide

  • erepdekinra

  • fasedienol

  • feniralstat

  • fosgonimeton

  • frexalimab

  • gemlapodect

  • golcadomide

  • gorivitug

  • idecabtagene vicleucel

  • imaradenant

  • inaxaplin

  • ispectamab tazide

  • itruvone

  • luveltamab tazevibulin

  • luvixasertib

  • modakafusp alfa

  • nadravaleucel

  • nexiguran

  • ocifisertib

  • onvansertib

  • oplunofusp

  • orpibestrant

  • palupiprant

  • pelecopan

  • pezadeftide

  • plixorafenib

  • pomlucabtagene autoleucel

  • rencofilstat

  • revumenib

  • rifaquizinone

  • rifasutenizol

  • rilunermin alfa

  • rovaleucel

  • sepiapterin

  • taniraleucel

  • tiomolibdic acid/tiomolibdate choline

  • trotabresib

  • tulisokibart

  • ultevursen

  • ulviprubart

  • unesbulin

  • upifitamab rilsodotin

  • utreloxastat

  • vanzacaftor

  • varokibart

  • veligrotug

  • vepdegestrant

  • vevoctadekin

  • vipivotide tetraxetan

  • voluloride

  • zelenectide pevedotin

  • zeltociclib

  • ziclumeran

  • zimislecel


To learn more about our creative services or speak with a branding expert, please contact us.

Author: Brittany Scott Last Updated: February 28, 2025